Related Experiment Videos

Genetic aspects of drug disposition and therapeutics

R J Guttendorf¹, P J Wedlund

¹Pharmacokinetics/Drug Metabolism Department, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105.

Journal of Clinical Pharmacology

|February 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.

Pharmacopsychiatry·2007

CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing.

The pharmacogenomics journal·2006

Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism.

Clinical nephrology·2002

[Distinguishing CYP2D6 homozygous and heterozygous extensive metabolizers by dextromethorphan phenotyping].

Yao xue xue bao = Acta pharmaceutica Sinica·2001

The CYP2C19 enzyme polymorphism.

Pharmacology·2000

Correlation between cytochrome P-450 CYP2D6 (CYP2D6) genotype and phenotype.

Zhongguo yao li xue bao = Acta pharmacologica Sinica·2000

See all related articles